Explore ›
Finding
Finding
null
Among pediatric APL patients who survived induction and achieved complete remission, FLT3 mutation status was not associated with differences in overall survival, event-free survival, or relapse-free survival, suggesting that FLT3 mutations exert their adverse effect exclusively during induction.
| Follow-up | 5 years |
| Comparator | FLT3 wild-type (FLT3/WT) pediatric APL patients who achieved complete remission |
| Effect summary | null |
Connected entities
Interventions
Outcomes
Populations
Source
PMC3368997
FLT3 Mutation Status is a Predictor of Early Death in Pediatric Acute Promyelocytic Leukemia: A Report From The Children's Oncology Group